Strata Critical Medical Inc Warrants
SRTAW
SRTAW was delisted on the 6th of May, 2026.
12 hedge funds and large institutions have $1.62M invested in Strata Critical Medical Inc Warrants in 2023 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 0 closing their positions.
20% more funds holding
Funds holding: 10 → 12 (+2)
0.02% more ownership
Funds ownership: 9.6% → 9.62% (+0.02%)
63% less capital invested
Capital invested by funds: $4.41M → $1.62M (-$2.79M)
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Walleye Capital
New York
|
+$185K |
| 2 |
TPCW
TD Private Client Wealth
New York
|
+$282 |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$32 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ICM
Ionic Capital Management
New York
|
-$146K |
| 2 |
HF
HRT Financial
New York
|
-$3K |
| 3 |
CAC
Cowen and Company
New York
|
-$235 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Walleye Capital
New York
| $551K | +$185K | +393,510 | +20% |
|
2
Goldman Sachs
New York
| $529K | – | – | – |
|
|
LP
3
LMR Partners
London,
United Kingdom
| $237K | – | – | – |
|
4
Morgan Stanley
New York
| $161K | – | – | – |
|
|
ICM
5
Ionic Capital Management
New York
| $113K | -$146K | -311,072 | -39% |
|
|
CAC
6
Cowen and Company
New York
| $10.9K | -$235 | -500 | -1% |
|
|
SCM
7
Saba Capital Management
New York
| $7.49K | – | – | – |
|
8
Two Sigma Investments
New York
| $6.28K | – | – | – |
|
|
HF
9
HRT Financial
New York
| $3K | -$3K | -6,387 | -30% |
|
|
TPCW
10
TD Private Client Wealth
New York
| $138 | +$282 | +600 | New |
|
|
11
UBS Group
Zurich,
Switzerland
| $16 | +$32 | +69 | New |
|
|
TRCT
12
Tower Research Capital (TRC)
New York
| $5 | – | – | – |
|
SRTAW Hedge Fund Activity: Q3 2023 in Review
12 of the 6,303 institutional investors tracked by Wall St. Rank reported a position in Strata Critical Medical Inc Warrants (SRTAW) for Q3 2023, worth a combined $1.62M — down 63% from $4.41M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new SRTAW positions and 0 closed out — a net gain of 2 holders — while 1 added to existing stakes and 3 trimmed.
The largest buyer was Walleye Capital, adding an estimated $185K. The largest seller was Ionic Capital Management, cutting an estimated $146K.
- 12 institutional investors held Strata Critical Medical Inc Warrants (SRTAW) as of Q3 2023, up from 10 in Q2 2023.
- Funds reported $1.62M of Strata Critical Medical Inc Warrants stock for Q3 2023, down 63% quarter-over-quarter.
- 2 funds opened new Strata Critical Medical Inc Warrants positions in Q3 2023 and 0 closed out, a net change of +2 holders.
- The largest Strata Critical Medical Inc Warrants buyer in Q3 2023 was Walleye Capital, an estimated $185K added.
- The largest Strata Critical Medical Inc Warrants seller in Q3 2023 was Ionic Capital Management, an estimated $146K sold.
Based on aggregated 13F filings for Q3 2023.